Bullish: CRISPR Therapeutics is a leader in gene therapy, has a strong current ratio of debt to equity, and a forward price to earnings ratio of -7.64



Bearish: CRISPR Therapeutics has a historical correlation of -0.14 between realized price and AI price forecast, and an average ratio of downside implied volatility to upside implied volatility of 0.96.




CRISPR Therapeutics Forecast

CRISPR Therapeutics (CRSP)

      

Complement Helium's AI CRSP Forecast with Balanced News and Deepen Your Understanding